RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Clinical trials for RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope pill tested for tough blood cancers
Disease control Not yet recruitingThis is a first-in-human study testing a new oral medication called APG-3288 for people with advanced blood cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will al…
Matched conditions: RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New hope for Tough-to-Treat blood cancers: first patients sought for groundbreaking drug trial
Disease control Not yet recruitingThis is the first study in people for a new drug called QLS2313, designed for patients with advanced blood cancers like lymphoma or leukemia that have come back or stopped responding to other treatments. The main goal is to find a safe and tolerable dose by giving the drug to sma…
Matched conditions: RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC